Anti-payload Antibodies: Facilitating ADC PK studies
Antibody-drug conjugates (ADCs) are a new class of biotherapeutics, consisting of acytotoxic payload covalently bound to an antibody by a linker. Evaluating the pharmacokinetics (PK) properties of ADCs in preclinical and clinical studies is essential for their strategic design and successful development.
Sino Biological has successfully developed anti-payload antibodies which are used for analyzing the plasma/serum PK profiles, DAR values, and drug load distribution of ADC drugs. Anti-payload antibodies are used to evaluate the safety and efficacy of ADC drugs in the preclinical and clinical stages, empowering the ADC drug development process.
As a great partner for pharmaceutical industry, Sino Biological is proud to announce the launch of anti-payload mAbs FREE trial campaign.
Additionally, our product line includes anti-DM1/DM4/SN-38/Dxd mAbs, currently under development, catering to the evolving needs of our clients. Reach out today to get your own trial-size and experience the reliability and quality that Sino Biological brings to the pharmaceutical industry.
Discover More Now!
Contact
Sino Biological Europe GmbH
Düsseldorfer Str. 40, 65760 Eschborn, Germany
+49(0)6196 9678656
order_eu@sinobiologicaleu.com
www.sinobiological.com
Adcendo ApS
Medilink Therapeutics
Biocytogen Co Ltd